Judge Amends Order In Semaglutide Spat With Drug Maker, Compounding Pharmacy

( July 1, 2025, 2:19 PM EDT) -- TAMPA, Fla. — A Florida federal judge on June 30 granted Novo Nordisk Inc.’s motion to amend the court’s order granting summary judgment in favor of a pharmaceutical company accused of selling unapproved compounded drugs containing semaglutide XE "semaglutide" , ruling that the motion for summary judgment is moot and that the drug manufacturer’s complaint is dismissed without prejudice....

Attached Documents

Related Sections